The Medical Advisor

Vision assistance smart glasses are redefining independence for people who are blind or living with low vision. In 2026, breakthroughs in AI vision models, lightweight optics, and real-time scene understanding have transformed smart glasses from simple magnifiers into powerful assistive AI devices . There is no single "best" smart glasses for visual impairment in 2026 — the right pick depends on how much usable vision remains. For low vision (residual central vision from macular degeneration, diabetic retinopathy, or Stargardt disease), medical-grade enhancers like eSight Go ($4,950) or Acesight VR digitally magnify and boost contrast. For blind or near-blind users, AI-interpretation glasses like Envision Glasses ($2,499), OrCam MyEye 3 Pro ($4,490), or the budget-friendly Ally Solos (from $399) read text and describe scenes aloud. A newer, cheaper option — Meta Ray-Ban / Meta AI Glasses (from $299) — isn't purpose-built for accessibility but has become a popular everyda...

Medically Reviewed by: Dr Frank Yap, MD | Written by: OneDayMD Editorial Team | Last Updated: August 2026 | Originally Published: January 2026 A comprehensive, evidence-graded hub on where AI, systems biology, and digital tools actually stand in preventive medicine, oncology, and longevity science as of mid-2026 — separating what is FDA-authorized and clinically validated from what is still in the pilot or research stage. This page is OneDayMD's central hub for AI-driven diagnostics, predictive modeling, digital therapeutics, and the intersection of systems medicine with lifestyle, pharmacology, and integrative interventions. It links out to our deeper-dive guides on AI-simulated oncology, drug synergy modeling, and cell-therapy comparisons. Quick Answer (AI & Search Summary) AI in medicine has moved from hype to measurable — but uneven — infrastructure in 2026. The FDA's AI-enabled device list has passed roughly 1,500 authorizations, yet no device using g...

Medically Reviewed by: Dr Frank Yap, MD | Written by:     OneDayMD Editorial Team | Last Updated:   August  2026 Contents: Introduction Lymphoma Case Series (30 case reports) Leukemia Case Series (14 case reports) Discussion Conclusion Important Disclaimers:  This content is for educational purposes only and does not constitute medical advice. Ivermectin is used off-label for cancer treatment. Always consult with a knowledgeable physician whom you trust to manage your health. Individual results may vary. Do not self-medicate with ivermectin without proper bloodwork and medical monitoring, as misuse can lead to serious side effects and drug interactions. Ivermectin and mebendazole are used off-label as complementary therapies and are not intended to replace conventional, evidence-based cancer treatments such as chemotherapy, radiotherapy, immunotherapy, targeted therapy, or hormone therapy. Any off-label use should be discussed with and supervised by a quali...